Medtronic (MDT) is reportedly looking at adjusting its global manufacturing footprint amid heightened concerns that the U.S.

Proposed legislation would designate AI as a medical ‘practitioner’ authorized to prescribe drugs on its own. Experts say the ...

Medical device maker Medtronic is looking at options to modify its global manufacturing footprint as part of efforts to ...

But thermodynamics are completely different in an isochoric system, where volume remains constant and pressure changes.” In ...

In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...

After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...

The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with ...

Medtronic ( MDT 2.27%) and Johnson & Johnson ( JNJ 1.64%) are two very healthy, high-yielding dividend stocks. This makes ...

T here is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...

The closed-loop system dynamically self-adjusts DBS therapy to individual brain activity in real time, providing personalized ...

The strategic partnership aims to increase access to Brainomix's AI technology for stroke treatment in Western Europe.